ClinicalTrials.govpublic full text
Evaluating Omission of Granulocyte Colony-stimulating Factors in Breast Cancer Patients Receiving Paclitaxel Portion of Dose-dense Adriamycin-cyclophosphamide and Paclitaxel Chemotherapy
early-stage breast cancer, filgrastim, pegfilgrastim, bone pain, paclitaxel, interventional, phase4
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 917772
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.